Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 30,776 | 36,116 | 27,802 | 17,981 | 8,503 |
| Cost of Goods | 30,396 | 26,550 | 21,857 | 14,107 | 5,730 |
| Gross Profit | 380 | 9,566 | 5,945 | 3,874 | 2,773 |
| Operating Expenses | 104,759 | 225,361 | 138,500 | 81,082 | 42,054 |
| Operating Income | -103,983 | -215,245 | -131,698 | -77,101 | -38,551 |
| Interest Expense | 0 | 0 | 298 | 927 | 2,519 |
| Other Income | -8,001 | -17,186 | 1,284 | -124 | -7 |
| Pre-tax Income | -111,984 | -232,431 | -130,712 | -78,152 | -41,077 |
| Income Tax | 33 | 62 | 1,884 | -5,717 | 29 |
| Net Income Continuous | -112,017 | -232,493 | -132,596 | -72,435 | -41,106 |
| Net Income | $-112,017 | $-232,493 | $-132,596 | $-72,435 | $-41,106 |
| EPS Basic Total Ops | -88.13 | -408.60 | -274.25 | -155.69 | -233.53 |
| EPS Basic Continuous Ops | -88.13 | -408.60 | -274.54 | -156.71 | -236.11 |
| EPS Diluted Total Ops | -88.13 | -408.60 | -274.25 | -155.69 | -233.53 |
| EPS Diluted Continuous Ops | -88.13 | -408.60 | -274.54 | -156.71 | -236.11 |
| EPS Diluted Before Non-Recurring Items | -70.91 | -303.59 | -275.45 | -155.69 | -233.53 |
| EBITDA(a) | $-70,523 | $-124,592 | $-121,220 | $-73,402 | $-37,072 |